Related Experiment Video
Updated: Aug 20, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia
Anne Marie Valente1, Rajiv Jain, Mark Scheurer
1Department of Pediatrics, Duke University, Box 3090, Durham, NC 27710, USA. valen010@mc.duke.edu
Insights
Infective endocarditis (IE) affects 20% of children with Staphylococcus aureus bacteremia (SAB). Congenital heart disease and multiple positive blood cultures increase IE risk in pediatric SAB patients, who face high mortality.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Medical Diagnostics
Background:
- Staphylococcus aureus bacteremia (SAB) is a serious infection in children.
- The risk of infective endocarditis (IE) in pediatric SAB cases is not well-established.
- Early diagnosis and management of IE are critical for improving outcomes.
Purpose of the Study:
- To prospectively determine the prevalence of infective endocarditis (IE) in pediatric patients diagnosed with Staphylococcus aureus bacteremia (SAB).
- To identify risk factors associated with IE in this population.
- To assess the mortality rates in children with SAB and IE.
Main Methods:
- Prospective study of pediatric patients with SAB between July 1998 and June 2001.
- Echocardiography performed on all eligible children with parental consent.
- Classification of endocarditis using modified Duke criteria and collection of clinical data.
Main Results:
- Of 51 children with SAB, 20% had definite or possible IE.
- Congenital heart disease was associated with a significantly higher IE prevalence (53% vs 3%).
- High mortality rates were observed in children with SAB, particularly those with IE (40% vs 12%).
Conclusions:
- The prevalence of definite IE in children with SAB is approximately 12%.
- Congenital heart disease and multiple positive blood cultures are significant risk factors for IE in pediatric SAB.
- Mortality for children with SAB and IE is notably high, underscoring the need for vigilant diagnosis and treatment.
Purpose:
The prevalence of infective endocarditis (IE) among children with Staphylococcus aureus bacteremia (SAB) is unknown. The objective of this study was to determine prospectively the prevalence of IE among pediatric patients with SAB in a large tertiary care center.
Methods:
Between July 1998 and June 2001, all children who developed SAB whose parent/guardian signed informed consent underwent echocardiography. Clinical and follow-up results were collected prospectively. Endocarditis was classified according to the modified Duke criteria.
Results:
Fifty-one children developed SAB during the study interval. Definite (6 patients [11.8%]) or possible (4 patients [7.8%]) IE was present in 10 of 51 (20%) children with SAB. Most children (73%) developed bacteremia as a consequence of an infected intravascular device. Children with underlying congenital heart disease had a significantly higher prevalence of definite or possible IE, compared with those with structurally normal hearts (53% vs 3%). All patients with definite IE had multiple positive blood cultures. Mortality was high among patients with and without IE (40% vs 12%).
Conclusions:
In this study, the prevalence of definite IE among children with SAB was approximately 12% and was frequently associated with congenital heart disease and multiple positive blood cultures. The mortality for children with SAB and definite or possible S aureus IE is high.
Related Concept Videos
Staphylococcal Skin Infections
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Development of the Oral Microbiota
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...